Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut epithelial surfaces and mucus are structural and protective features of the gastrointestinal tract. The epithelial surface consists of a single layer of cells, primarily enterocytes and goblet cells, that are covered by a mucus layer. The mucus is a viscoelastic gel mainly made of the glycoprotein mucin—especially MUC2 in the intestine—secreted by goblet cells. This layer acts as a **physical and biochemical barrier** against pathogens, facilitates the maintenance of the microbiota, regulates immune responses, and protects underlying tissues from mechanical and chemical damage[6][4][3][7][1]. Mucus thickness and composition vary through regions of the gut, being denser and more stratified in the colon than in the small intestine[4][3][5]. Impairment or alteration of these structures is central in many gastrointestinal diseases, but they are not considered classical molecular drug targets, rather they represent complex anatomical and biochemical barriers[6][2][5][4][1]. This entry is likely **not appropriate for direct mapping as a molecular pharmacology target**. It is instead a composite of tissue anatomy and barrier biochemistry encompassing multiple molecular components. If mapping to molecular targets is needed, focus would shift to specific components such as secretory mucins (e.g., "Mucin-2" or "MUC2"), transmembrane mucins, or specific epithelial cell markers.
Enhance mucus secretion or hydration (lubiprostone) Anti-inflammatory effects at mucosal surfaces (aminesalicylates, corticosteroids) Modulate barrier permeability and epithelial healing (biologics in IBD) Restore ion channel function (CFTR modulators)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut epithelial surface and mucus layer (null).